Dr. Michael Jeffrey Perlmutter, MD Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1300 W Lexington Ave, Suite 2, Winchester, KY 40391 Phone: 859-901-9907 Fax: 859-901-9904 |
News Archive
Teva Pharmaceutical Industries Ltd. today announced results from a Phase III study of QNAZE™ (beclomethasone dipropionate [BDP]) HFA, its nasal aerosol corticosteroid in development for the treatment of perennial allergic rhinitis (PAR) and seasonal allergic rhinitis (SAR).
The victor of the presidential contest will face huge policy decisions including how to maintain Medicare's solvency and whether to implement the 2010 health law. News outlets analyze where President Barack Obama and GOP presidential hopeful Mitt Romney stand on these issues.
Mosquitoes are deadly efficient disease transmitters. Research conducted at Michigan State University, however, demonstrates that they also can be equally adept in curing diseases such as malaria.
The effectiveness of current treatments for melanoma, the deadliest form of skin cancer, could be improved by using approaches that wipe out the 'survival system' of cancer cells according to a study published in Nature Communications today.
MDS Nordion, a leading provider of products and services to the global health science market, today announced it has extended its existing agreement with Ontario Power Generation Inc., the Canadian-based electricity generation company, until 2020 for the secure supply of cobalt-60 used in gamma sterilization technologies around the world.
› Verified 9 days ago